GleamWall
中文EN

VOGX Vogenx, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1903784 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets1.0%
Debt / equity0.00x
Current ratio98.33x
Interest coverage—

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q32025-09-302025Q22025-06-302025Q12025-03-31
Income statement
Revenue——————
R&D expense$1.08M$156,786—$124,813$136,392—
SG&A expense$703,736$198,598—$177,664$174,268—
Net income-$4.91M-$384,430-$475,452-$284,407-$294,797-$356,619
EPS (basic)-0.47-0.07—-0.05-0.05—
EPS (diluted)-0.47-0.07—-0.05-0.05—
Weighted avg. shares (diluted)10.40M5.45M—5.45M5.45M—
Balance sheet
Cash & equivalents$5.13M$193,017—$234,348$390,276—
Short-term investments$76.99M—————
Current assets$82.84M$1.41M————
Total assets$82.84M$1.41M————
Current liabilities$842,470$3.19M————
Total liabilities$842,470$3.19M————
Shareholders' equity$82.00M-$1.78M-$1.40M-$418,376-$136,590$155,586
Shares outstanding14.86M5.26M————
Cash flow statement
Operating cash flow-$2.59M——-$155,928——
Financing cash flow$84.51M——$0——
Stock-based compensation$4,708——$2,621——

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.